Multiple Sclerosis

Produk Detail:
  • Author : Neil Scolding
  • Publisher : Oxford University Press, USA
  • Pages : 96 pages
  • ISBN : 0199603251
  • Rating : 5/5 from 1 reviews
CLICK HERE TO GET THIS BOOK >>>Multiple Sclerosis

Download or Read online Multiple Sclerosis full in PDF, ePub and kindle. this book written by Neil Scolding and published by Oxford University Press, USA which was released on 05 July 2012 with total page 96 pages. We cannot guarantee that Multiple Sclerosis book is available in the library, click Get Book button and read full online book in your kindle, tablet, IPAD, PC or mobile whenever and wherever You Like. Part of the Oxford Neurology Library series, this practical pocketbook will summarise the latest understanding of what might cause the disease, the methods of diagnosis and assessment, and current management techniques.

Multiple Sclerosis

Multiple Sclerosis
  • Author : Neil Scolding,Alastair Wilkins
  • Publisher : Oxford University Press, USA
  • Release : 05 July 2012
GET THIS BOOK Multiple Sclerosis

Part of the Oxford Neurology Library series, this practical pocketbook will summarise the latest understanding of what might cause the disease, the methods of diagnosis and assessment, and current management techniques.

Multiple Sclerosis 3 Volume 34 E Book

Multiple Sclerosis 3  Volume 34 E Book
  • Author : Claudia Lucchinetti,Reinhard Hohlfeld
  • Publisher : Elsevier Health Sciences
  • Release : 29 October 2009
GET THIS BOOK Multiple Sclerosis 3 Volume 34 E Book

Multiple Sclerosis 3 emphasizes the latest in the pharmacologic treatment of this incurable inflammatory demyelinating disorder. Primary editors Claudia Lucchinetti, MD, and Reinhard Hohlfeld, MD, with the aid of all new contributors, present a complete and current reference on multiple sclerosis that includes discussions of such hot topics as Biomarkers, Genomics, and Surrogate Outcomes in MS; Pediatric MS; Transverse Myelitis; Attack Therapies in MS; Current Disease-Modifying Therapeutic Strategies in MS; Management of Aggressive MS; Symptomatic Therapies in MS; Complementary and Alternative

Biomarkers in Multiple Sclerosis

Biomarkers in Multiple Sclerosis
  • Author : U. Utz
  • Publisher : IOS Press
  • Release : 01 November 2006
GET THIS BOOK Biomarkers in Multiple Sclerosis

"Several processes are presumed to sequentially or simultaneously contribute to the pathophysiology of multiple sclerosis (MS). Biomarkers indicative of these processes would hold great potential for (1) MS diagnostics and identification of disease stages and subcategories; (2) prediction of onset and disease course; (3) treatment selection and improved prognosis of treatment success; and (4) the evaluation of novel therapeutics. Though it is unlikely that any one marker could function as a true surrogate or stand alone, biomarker combinations or patterns could provide insight into

Handbook of Multiple Sclerosis

Handbook of Multiple Sclerosis
  • Author : Stuart D. Cook
  • Publisher : CRC Press
  • Release : 30 March 2001
GET THIS BOOK Handbook of Multiple Sclerosis

Reporting on the latest advances made in treating multiple sclerosis (MS) and continuing the high standards set by earlier editions, the Handbook of Multiple Sclerosis, Third Edition examines a wide range of topics from etiology to treatment options. Analyzes recent developments in the natural history, immunopathology, lesion evolution, and

McAlpine s Multiple Sclerosis

McAlpine s Multiple Sclerosis
  • Author : Douglas McAlpine,Alastair Compston
  • Publisher : Elsevier Health Sciences
  • Release : 11 August 2022
GET THIS BOOK McAlpine s Multiple Sclerosis

Comprehensive text highlighting current clinical research in the area of multiple sclerosis. Includes expanded coverage of genetics, neurobiology, pathophysiology, and historical background.

Biomarkers and Disease Activity in Multiple Sclerosis

Biomarkers and Disease Activity in Multiple Sclerosis
  • Author : Irene Håkansson
  • Publisher : Linköping University Electronic Press
  • Release : 07 October 2019
GET THIS BOOK Biomarkers and Disease Activity in Multiple Sclerosis

This thesis focuses on disease activity in clinically isolated syndrome (CIS) and newly diagnosed relapsing remitting multiple sclerosis (RRMS). The papers are based on data from 41 patients in a prospective longitudinal cohort study. All patients were untreated at baseline. Age- and sex-matched healthy controls (n=22) for blood and cerebrospinal fluid (CSF) samples were recruited from blood donors. Paper I evaluated the prognostic value of baseline levels of CXCL1, CXCL8, CXCL10, CXCL13, CCL22, neurofilament light chain (NFL), neurofilament heavy chain, glial

Experimental Models of Multiple Sclerosis

Experimental Models of Multiple Sclerosis
  • Author : Ehud Lavi,Cris S. Constantinescu
  • Publisher : Springer Science & Business Media
  • Release : 03 January 2008
GET THIS BOOK Experimental Models of Multiple Sclerosis

Multiple Sclerosis (MS) is an enigmatic immune mediated disease of the central nervous system that affects about 350,000 individuals in the US, and many more around the world. The mechanism of this disease is largely unknown and there is no cure for it. However, there are several well-characterized experimental animal models that help us understand and speculate about potential mechanisms of pathology in this disease. Many of the experimental therapies designed for this disease rely on testing the drugs in animal

Emerging Drugs and Targets for Multiple Sclerosis

Emerging Drugs and Targets for Multiple Sclerosis
  • Author : Ana Martinez
  • Publisher : Royal Society of Chemistry
  • Release : 18 June 2019
GET THIS BOOK Emerging Drugs and Targets for Multiple Sclerosis

Multiple sclerosis (MS) is a complex disease with a presumed autoimmune aetiology and few current effective treatments. Disease modifying therapies focus on the altering the natural course of relapsing and remitting MS, targeting the inflammatory response. Other targets involve tacking the cause of the disease – demyelination of axons through remyelination therapies. Due to several recent breakthroughs in the understanding of the pathophysiology of MS new targets for remyelination and immunomodulation are rapidly emerging. This book provides a comprehensive overview of

Primer on Multiple Sclerosis

Primer on Multiple Sclerosis
  • Author : Barbara S. Giesser
  • Publisher : Oxford University Press
  • Release : 11 February 2016
GET THIS BOOK Primer on Multiple Sclerosis

Primer on Multiple Sclerosis, 2nd Edition is an updated reference manual for the practicing clinician. It covers the range of information needed to treat persons with MS, beginning with basic science and immunopathology, thorough differential diagnosis, symptom management and disease modifying therapies. This essential book also includes material covering new and experimental strategies as well as a review of commonly used complementary and alternative modalities that are used by persons with MS.Multiple Sclerosis (MS) is the most common demyelinating